Story
Abbott Labs Stock Rises on Google Health Partnership for Lingo Wearable

Abbott Laboratories (NYSE: ABT) stock rose in morning trading after the healthcare company announced a multi-year collaboration with Google Health. The partnership will integrate Abbott's Lingo biowearable, a continuous glucose monitor, with Google's artificial intelligence and consumer technology platforms.
Partnership Integrates Lingo with Google's Ecosystem
The agreement will allow users of the Lingo device to view their real-time glucose data directly within the Google Health app. According to the announcement, this integration aims to provide a more holistic view of a user's health.
Key features of the collaboration include:
- Data Integration: Lingo users can see their glucose trends alongside other health metrics tracked by Google.
- AI-Powered Coaching: The partnership will leverage Google Health Coach to provide users with personalized recommendations on nutrition, activity, sleep, and recovery based on their health data.
Research Initiative and Strategic Expansion
AdBeyond the consumer-facing app integration, the collaboration includes one of the largest real-world metabolic health studies ever conducted. The research will combine continuous glucose data with information from other wearables, lab results, and surveys. Findings are expected to enhance future AI coaching features in Google Health and inform the development of new capabilities for the Lingo platform itself.
For investors, the deal signals Abbott's strategy to expand Lingo's addressable market beyond the insulin-using population into the broader consumer wellness space. By embedding its sensor technology into a major consumer platform, Abbott is positioning Lingo for a significantly larger audience.
Market Reaction
Following the news, shares in Abbott Laboratories climbed 1.2% in an otherwise quiet session for the broader market. The move was driven by company-specific news, as there were no major macroeconomic data releases to influence trading.
The partnership provides a new growth narrative for Abbott's digital health ambitions and its Lingo platform, which had already been gaining commercial traction. The combination of a high-profile technology partner and a clear path to wider consumer adoption supported the stock's advance.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.